Byrne Asset Management LLC Pfizer Inc Transaction History

Byrne Asset Management LLC

$116 Million
Q2 2024

A detailed history of Byrne Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Byrne Asset Management LLC holds 32,665 shares of PFE stock, worth $971,783. This represents 0.78% of its overall portfolio holdings.

Number of Shares

32,665

Previous 34,145 4.33%

Holding current value

$971,783

Previous $947,000 3.59%

% of portfolio

0.78%

Previous 0.79%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $37,384 - $43,808	-1,480 Reduced 4.33%	32,665 $913,000
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $27,521 - $31,602	-1,063 Reduced 3.02%	34,145 $947,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $109,876 - $142,717	-4,205 Reduced 10.67%	35,208 $1.01 Million
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $44,605 - $52,138	-1,390 Reduced 3.41%	39,413 $1.31 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $27,089 - $31,342	750 Added 1.87%	40,803 $1.5 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $25,012 - $32,562	-635 Reduced 1.56%	40,053 $1.63 Million
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $64,086 - $83,657	-1,535 Reduced 3.64%	40,688 $2.09 Million
Q3 2022 Oct 19, 2022	BUY	$43.76 - $53.42 $7,439 - $9,081	170 Added 0.4%	42,223 $1.85 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $6,979 - $8,275	-150 Reduced 0.36%	42,053 $2.21 Million
Q1 2022 Apr 05, 2022	BUY	$45.75 - $56.69 $76,631 - $94,955	1,675 Added 4.13%	42,203 $2.19 Million
Q4 2021 Feb 22, 2022	BUY	$41.32 - $61.25 $1.67 Million - $2.48 Million	40,528 New	40,528 $2.39 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.

Account

Byrne Asset Management LLC Pfizer Inc Transaction History